136 related articles for article (PubMed ID: 37393154)
1. Reassessing surgical guidelines for papillary thyroid cancer impact on survival: Expanding indications for lobectomy.
Stevens A; Meier J; Bhat A; Knight SJ; Vanness DJ; Balentine C
Surgery; 2023 Sep; 174(3):542-548. PubMed ID: 37393154
[TBL] [Abstract][Full Text] [Related]
2. Total thyroidectomy versus unilateral lobectomy for unilateral multifocal papillary thyroid carcinoma: systematic review and meta‑analysis.
Chen H; Liu Y; Huang D; Zhang X; She L
Updates Surg; 2024 Jan; 76(1):33-41. PubMed ID: 38127193
[TBL] [Abstract][Full Text] [Related]
3. Thyroid lobectomy for papillary thyroid cancer: long-term follow-up study of 1,088 cases.
Matsuzu K; Sugino K; Masudo K; Nagahama M; Kitagawa W; Shibuya H; Ohkuwa K; Uruno T; Suzuki A; Magoshi S; Akaishi J; Masaki C; Kawano M; Suganuma N; Rino Y; Masuda M; Kameyama K; Takami H; Ito K
World J Surg; 2014 Jan; 38(1):68-79. PubMed ID: 24081532
[TBL] [Abstract][Full Text] [Related]
4. Changes in total thyroidectomy versus thyroid lobectomy for papillary thyroid cancer during the past 15 years.
James BC; Timsina L; Graham R; Angelos P; Haggstrom DA
Surgery; 2019 Jul; 166(1):41-47. PubMed ID: 30904172
[TBL] [Abstract][Full Text] [Related]
5. Total thyroidectomy versus thyroid lobectomy for papillary thyroid cancer: Comparative analysis after propensity score matching: A multicenter study.
Kuba S; Yamanouchi K; Hayashida N; Maeda S; Adachi T; Sakimura C; Kawakami F; Yano H; Matsumoto M; Otsubo R; Sato S; Fujioka H; Kuroki T; Nagayasu T; Eguchi S
Int J Surg; 2017 Feb; 38():143-148. PubMed ID: 27677707
[TBL] [Abstract][Full Text] [Related]
6. Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients.
Adam MA; Pura J; Gu L; Dinan MA; Tyler DS; Reed SD; Scheri R; Roman SA; Sosa JA
Ann Surg; 2014 Oct; 260(4):601-5; discussion 605-7. PubMed ID: 25203876
[TBL] [Abstract][Full Text] [Related]
7. Total thyroidectomy versus lobectomy for intermediate-risk papillary thyroid carcinoma: A single-institution matched-pair analysis.
Liu J; Zhang Z; Huang H; Xu S; Liu Y; Liu S; Wang X; Xu Z
Oral Oncol; 2019 Mar; 90():17-22. PubMed ID: 30846171
[TBL] [Abstract][Full Text] [Related]
8. Thyroid lobectomy is not sufficient for T2 papillary thyroid cancers.
Rajjoub SR; Yan H; Calcatera NA; Kuchta K; Wang CE; Lutfi W; Moo-Young TA; Winchester DJ; Prinz RA
Surgery; 2018 May; 163(5):1134-1143. PubMed ID: 29426618
[TBL] [Abstract][Full Text] [Related]
9. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.
Mazzaferri EL; Jhiang SM
Am J Med; 1994 Nov; 97(5):418-28. PubMed ID: 7977430
[TBL] [Abstract][Full Text] [Related]
10. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
11. Total thyroidectomy versus lobectomy in conventional papillary thyroid microcarcinoma: Analysis of 8,676 patients at a single institution.
Kim SK; Park I; Woo JW; Lee JH; Choe JH; Kim JH; Kim JS
Surgery; 2017 Feb; 161(2):485-492. PubMed ID: 27593085
[TBL] [Abstract][Full Text] [Related]
12. Total thyroidectomy versus lobectomy: surgical approach to T1-T2 papillary thyroid cancer.
Di Filippo L; Giugliano G; Tagliabue M; Gandini S; Sileo F; Allora A; Grosso E; Proh M; Basso V; Scaglione D; Manzoni MF; Ansarin M
Acta Otorhinolaryngol Ital; 2020 Aug; 40(4):254-261. PubMed ID: 33100336
[TBL] [Abstract][Full Text] [Related]
13. Contralateral Low-to-Intermediate Suspicion Nodule Is Not a Contraindication for Lobectomy in Patients with Papillary Thyroid Carcinoma.
Pak SJ; Kwon D; Kim BC; Cho JW; Kim WW; Lee YM; Sung TY; Baek JH; Kim WG; Kim WB; Chung KW
Thyroid; 2023 Nov; 33(11):1339-1348. PubMed ID: 37624735
[No Abstract] [Full Text] [Related]
14. Should Contralateral Nodules Be an Indication of Total or Completion Thyroidectomy for Patients With Unilateral Papillary Thyroid Carcinoma?
Ma T; Wang H; Liu J; Zou J; Liu S
Front Endocrinol (Lausanne); 2021; 12():723631. PubMed ID: 34434171
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes of total thyroidectomy versus thyroid lobectomy for papillary thyroid microcarcinoma: comparative analysis after propensity score matching.
Lee J; Park JH; Lee CR; Chung WY; Park CS
Thyroid; 2013 Nov; 23(11):1408-15. PubMed ID: 23509895
[TBL] [Abstract][Full Text] [Related]
16. Total Thyroidectomy Versus Lobectomy for the Treatment of Follicular Thyroid Microcarcinoma.
Megwalu UC; Green RW
Anticancer Res; 2016 Jun; 36(6):2899-902. PubMed ID: 27272803
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Outcomes After Lobectomy for Patients with High-Risk Papillary Thyroid Carcinoma.
Sugitani I; Kazusaka H; Ebina A; Shimbashi W; Toda K; Takeuchi K
World J Surg; 2023 Feb; 47(2):382-391. PubMed ID: 35972533
[TBL] [Abstract][Full Text] [Related]
18. Total Thyroidectomy vs Thyroid Lobectomy for Localized Papillary Thyroid Cancer in Children: A Propensity-Matched Survival Analysis.
Memeh K; Ruhle B; Alsafran S; Vaghaiwalla T; Kaplan E; Angelos P; Keutgen XM
J Am Coll Surg; 2021 Jul; 233(1):39-49. PubMed ID: 33887483
[TBL] [Abstract][Full Text] [Related]
19. Causal inference between aggressive extrathyroidal extension and survival in papillary thyroid cancer: a propensity score matching and weighting analysis.
Xu M; Xi Z; Zhao Q; Yang W; Tan J; Yi P; Zhou J; Huang T
Front Endocrinol (Lausanne); 2023; 14():1149826. PubMed ID: 37293504
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of hemithyroidectomy in papillary thyroid carcinoma with minimal extrathyroidal extension.
Ji YB; Song CM; Kim D; Sung ES; Lee DW; Chung MS; Tae K
Eur Arch Otorhinolaryngol; 2019 Dec; 276(12):3435-3442. PubMed ID: 31414221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
